← Back to headlines
Hims & Hers Stock Falls After FDA Advisors Snub First Peptide
Shares of Hims & Hers declined following a decision by FDA advisors regarding the company's first peptide product.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
